Dr. Koss conducts clinical research on HIV prevention and treatment, with a major focus on developing strategies to optimize uptake of and adherence to pre-exposure prophylaxis (PrEP) among women in the United States and East Africa. She also has an interest in adherence to treatment and virologic outcomes among pregnant and postpartum women living with HIV. She is a clinical provider in HIV and Infectious Diseases at Zuckerberg San Francisco General Hospital.
Dr. Koss will examine preferences for long-acting HIV prevention products and care delivery among young women at risk for HIV in Kenya and Uganda and elucidate anticipated barriers to and facilitators of retention and adherence to PrEP formulations and care, including behavioral and structural drivers of product and service delivery preferences. These efforts will integrate end-user input into interventions tailored to the needs of young women in sub-Saharan Africa.
Dr. Koss received her AB degree with Honors in Biochemical Sciences from Harvard College and her MD degree from Northwestern University. She completed her clinical training in Infectious Disease and received advanced training in clinical research at UCSF